Detalles de la búsqueda
1.
The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse.
Eur Addict Res
; 28(1): 56-67, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569487
2.
Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial.
Am J Addict
; 30(5): 453-460, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487395
3.
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.
Am J Addict
; 28(2): 77-85, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30701613
4.
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial.
Eur Addict Res
; 25(6): 303-309, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31340204
5.
Interest in Extended Release Naltrexone among Opioid Users.
Eur Addict Res
; 22(6): 301-305, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27434137
6.
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial.
Contemp Clin Trials
; 135: 107360, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865138
7.
Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone.
Addiction
; 2020 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338285
8.
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.
JAMA Psychiatry
; 76(2): 127-134, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30566177
9.
Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial.
Addiction
; 113(10): 1840-1849, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29806872
10.
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
JAMA Psychiatry
; 74(12): 1197-1205, 2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29049469
11.
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).
BMC Pharmacol Toxicol
; 17(1): 18, 2016 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27121539
Resultados
1 -
11
de 11
1
Próxima >
>>